Канал: HCPLive

Edward V Loftus, Jr, MD: Discussing FDA Approval of Risankizumab (Skyrizi) in Ulcerative Colitis

Edward V Loftus, Jr, MD: Discussing FDA Approval of Risankizumab (Skyrizi) in Ulcerative Colitis

Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH

Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH

Frederic Lavie, MD, PhD: cDAPSA Demonstrates Efficacy in Monitoring Disease Activity in PsA

Frederic Lavie, MD, PhD: cDAPSA Demonstrates Efficacy in Monitoring Disease Activity in PsA

Noninvasive Testing, Candidate Biomarkers in AATD-Associated Liver Disease

Noninvasive Testing, Candidate Biomarkers in AATD-Associated Liver Disease

Discover Why Eating Early Improves Sleep, Cardiometabolic Health with Josiane Broussard, PhD

Discover Why Eating Early Improves Sleep, Cardiometabolic Health with Josiane Broussard, PhD

Michael Grandner, PhD, on Treating Sleep-Related Anxiety: Focus on Insomnia, Not Anxiety

Michael Grandner, PhD, on Treating Sleep-Related Anxiety: Focus on Insomnia, Not Anxiety

Naim Alkhouri, MD: Resmetirom Has Been a “Game Changer” in MASH Since FDA Approval

Naim Alkhouri, MD: Resmetirom Has Been a “Game Changer” in MASH Since FDA Approval

Revolutionizing Cardiovascular Risk: New Treatments and Modifiable Factors

Revolutionizing Cardiovascular Risk: New Treatments and Modifiable Factors

Therapies in Development for Hidradenitis Suppurativa

Therapies in Development for Hidradenitis Suppurativa

"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology

"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology

Advancements in Pediatric Psoriasis Treatment, with Lisa Swanson, MD

Advancements in Pediatric Psoriasis Treatment, with Lisa Swanson, MD

New Insight: A Look at the Oculenz with Michael Freeman, CEO of Ocutrx

New Insight: A Look at the Oculenz with Michael Freeman, CEO of Ocutrx

The JAK Inhibitor Safety Conversation

The JAK Inhibitor Safety Conversation

Secukinumab and Bimekizumab for Hidradenitis Suppurativa

Secukinumab and Bimekizumab for Hidradenitis Suppurativa

FDA's AdComm Reaction: MDMA capsules for PTSD

FDA's AdComm Reaction: MDMA capsules for PTSD

Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care

Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care

Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD

Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD

Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD

Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD

Bessel van der Kolk, MD: What MDMA Assisted Therapy Taught us About PTSD

Bessel van der Kolk, MD: What MDMA Assisted Therapy Taught us About PTSD

Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy

Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy

Deepak Sambhara, MD: Impact of CRT on Aflibercept 8 mg Outcomes in DME

Deepak Sambhara, MD: Impact of CRT on Aflibercept 8 mg Outcomes in DME

Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME

Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME

Mark Barakat, MD: Stable IOP Outcomes After Aflibercept 8 mg in DME

Mark Barakat, MD: Stable IOP Outcomes After Aflibercept 8 mg in DME

“We’re at a Complete Disconnect”: Marla Dubinsky, MD, on Bowel Urgency in IBD

“We’re at a Complete Disconnect”: Marla Dubinsky, MD, on Bowel Urgency in IBD

Navigating ACR’s RA Treatment Guidelines, with Bryant England, MD, PhD

Navigating ACR’s RA Treatment Guidelines, with Bryant England, MD, PhD

HCPLive Five at APA 2024

HCPLive Five at APA 2024

New Findings on Cytisinicline Treatment for Quitting E-Cigarettes, with Nancy Rigotti, MD

New Findings on Cytisinicline Treatment for Quitting E-Cigarettes, with Nancy Rigotti, MD

Addressing Cognitive Impairment in Heart Failure Management: Insights from HFSA Scientific Statement

Addressing Cognitive Impairment in Heart Failure Management: Insights from HFSA Scientific Statement

OCD, Body Dysmorphic Disorder, Trichotillomania: What Is the Difference?

OCD, Body Dysmorphic Disorder, Trichotillomania: What Is the Difference?

Discussing the Marginalization of IBS and Ways to Improve Care, with Mark Pimentel, MD

Discussing the Marginalization of IBS and Ways to Improve Care, with Mark Pimentel, MD

How does DSM-5-TR Compare to Previous Iterations to Diagnose Psychiatric Disorders?

How does DSM-5-TR Compare to Previous Iterations to Diagnose Psychiatric Disorders?

Nazlee Zebardast, MD, MSc: Utility of Genetic Risk Scores for Glaucoma Onset

Nazlee Zebardast, MD, MSc: Utility of Genetic Risk Scores for Glaucoma Onset

Tips for Assessing, Managing Headaches in Hospitalized Patients

Tips for Assessing, Managing Headaches in Hospitalized Patients

Roger A. Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME

Roger A. Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME

Leveraging Mammograms for Cardiovascular Risk Assessment in Women

Leveraging Mammograms for Cardiovascular Risk Assessment in Women

Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD

Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD

Dolly Chang, MD, PhD: Importance of Early Drying on Outcomes in DME

Dolly Chang, MD, PhD: Importance of Early Drying on Outcomes in DME

Discussing Risankizumb, Differences in IL-23 Inhibitor Epitopes with Christopher Bunick, MD, PhD

Discussing Risankizumb, Differences in IL-23 Inhibitor Epitopes with Christopher Bunick, MD, PhD

Value of Oral APX3330 for Diabetic Retinopathy Progression w/ Daniel Su, MD

Value of Oral APX3330 for Diabetic Retinopathy Progression w/ Daniel Su, MD

Addressing Access Barriers for Patients with IgG4-RD, with John H Stone, MD, MPH

Addressing Access Barriers for Patients with IgG4-RD, with John H Stone, MD, MPH

Machine Learning Predicts Functional Outcomes in DME w/ Daniela Ferrara, MD, PhD

Machine Learning Predicts Functional Outcomes in DME w/ Daniela Ferrara, MD, PhD

Ashkan M. Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy

Ashkan M. Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy

Breaking Stigma: Alcohol Use Disorder and Liver Disease | Insights from Expert Clinicians

Breaking Stigma: Alcohol Use Disorder and Liver Disease | Insights from Expert Clinicians

Audrey Chun, MD: Practical Recommendations to Give Older Patients for Exercise, Cognitive Health

Audrey Chun, MD: Practical Recommendations to Give Older Patients for Exercise, Cognitive Health

Integrative RA Treatment Guidelines, with Benjamin Smith, DMSc, PA-C

Integrative RA Treatment Guidelines, with Benjamin Smith, DMSc, PA-C

Managing Hospitalized Patients with Psychiatric Illness

Managing Hospitalized Patients with Psychiatric Illness

Brilaroxazine’s Role in Treating Schizophrenia, with Larry Ereshefsky, PharmD

Brilaroxazine’s Role in Treating Schizophrenia, with Larry Ereshefsky, PharmD

Melanie Jay, MD: Advancing Equitable Approaches to Improve Obesity Care

Melanie Jay, MD: Advancing Equitable Approaches to Improve Obesity Care

KarXT (xanomeline-trospium) for Schizophrenia: Long-Term Efficacy & Next Steps, with Rishi Kakar, MD

KarXT (xanomeline-trospium) for Schizophrenia: Long-Term Efficacy & Next Steps, with Rishi Kakar, MD

Unraveling the Current Landscape in Sickle Cell Disease with Elna Saah, MD

Unraveling the Current Landscape in Sickle Cell Disease with Elna Saah, MD

Digital Ischemia for the Rheumatologist, with Tracy Frech, MD

Digital Ischemia for the Rheumatologist, with Tracy Frech, MD

What Age Should Patients Get Screened for Colorectal Cancer?

What Age Should Patients Get Screened for Colorectal Cancer?

Experts' Perspectives: Advancements in Cardiomyopathy at ACC.24

Experts' Perspectives: Advancements in Cardiomyopathy at ACC.24

Bimekizumab Shows Favorable Efficacy Compared with Other DMARDs for PsA with Philip J Mease, MD

Bimekizumab Shows Favorable Efficacy Compared with Other DMARDs for PsA with Philip J Mease, MD

Depressed Black Individuals Are Less Likely to Use “I” Language Markers on Social Media

Depressed Black Individuals Are Less Likely to Use “I” Language Markers on Social Media

Top Trials and Data at ACC.24, with Deepak Bhatt, MD, MPH, MBA

Top Trials and Data at ACC.24, with Deepak Bhatt, MD, MPH, MBA

Facilitated Telemedicine’s Potential for Increasing Access to HCV Treatment with Andrew Talal, MD

Facilitated Telemedicine’s Potential for Increasing Access to HCV Treatment with Andrew Talal, MD

Reflecting on Latest Updates in Psoriasis Research with Raj Chovatiya, MD, PhD

Reflecting on Latest Updates in Psoriasis Research with Raj Chovatiya, MD, PhD

HCPLive Five at ACC 2024

HCPLive Five at ACC 2024

MASH/MASLD Screening Discussions Post-Resmetirom Approval

MASH/MASLD Screening Discussions Post-Resmetirom Approval

Improving the Care Cascade for Children with Perinatal Hepatitis C Through Early Treatment

Improving the Care Cascade for Children with Perinatal Hepatitis C Through Early Treatment

Raj Chovatiya, MD, PhD: Takeaways from New Data on Vitiligo, Atopic Dermatitis, HS Treatments

Raj Chovatiya, MD, PhD: Takeaways from New Data on Vitiligo, Atopic Dermatitis, HS Treatments

Misconceptions about Autism with Alycia Halladay, PhD

Misconceptions about Autism with Alycia Halladay, PhD

Peter A. Campochiaro, MD: Phase 1/2a Data on RGX-314 Gene Therapy for Wet AMD

Peter A. Campochiaro, MD: Phase 1/2a Data on RGX-314 Gene Therapy for Wet AMD

HCPLive on Youtube

HCPLive on Youtube

Unveiling the Global Landscape of Rheumatoid Arthritis Clinical Trials, with Judith Ng-Cashin, MD

Unveiling the Global Landscape of Rheumatoid Arthritis Clinical Trials, with Judith Ng-Cashin, MD

Once-Weekly #insulin Could Change Lives in #Diabetes

Once-Weekly #insulin Could Change Lives in #Diabetes

2024 CRC Awareness Month: Updates in Colorectal Cancer Screening

2024 CRC Awareness Month: Updates in Colorectal Cancer Screening

How Valid Are Major Depressive Disorder Performance Measures? Review Sheds Insight

How Valid Are Major Depressive Disorder Performance Measures? Review Sheds Insight

HCPLive Five at AAD 2024

HCPLive Five at AAD 2024

Crisis Point: Stigma Hinders Adoption of Hepatitis C-Positive Donor Kidneys

Crisis Point: Stigma Hinders Adoption of Hepatitis C-Positive Donor Kidneys

HFSA Takes Aim at Cognitive Impairment in Heart Failure, with Eiran Gorodeski, MD, MPH

HFSA Takes Aim at Cognitive Impairment in Heart Failure, with Eiran Gorodeski, MD, MPH

Wegovy Approved for Cardiovascular Risk Reduction

Wegovy Approved for Cardiovascular Risk Reduction

The US Department of Veterans Affairs Announces Adoption of Adalimumab-bwwd, with Jon Martin

The US Department of Veterans Affairs Announces Adoption of Adalimumab-bwwd, with Jon Martin

Daylight Savings Time: Harmful or Beneficial? Sleep Expert Andrew Namen, MD, Weighs In

Daylight Savings Time: Harmful or Beneficial? Sleep Expert Andrew Namen, MD, Weighs In

The Importance of Head-to-Head Clinical Trials in IBD, with Marla Dubinsky, MD

The Importance of Head-to-Head Clinical Trials in IBD, with Marla Dubinsky, MD

New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

Redefining Time in Range for Diabetes Management

Redefining Time in Range for Diabetes Management

Robert Bissonnette, MD: Discussing the First Oral IL-23 Inhibitor for Psoriasis

Robert Bissonnette, MD: Discussing the First Oral IL-23 Inhibitor for Psoriasis

Comparing HbA1c and Time in Range for Predicting Diabetes Outcomes

Comparing HbA1c and Time in Range for Predicting Diabetes Outcomes

Advances in Research, Emerging Therapeutic Options in Vasculitis, with Anisha Dua, MD, MPH

Advances in Research, Emerging Therapeutic Options in Vasculitis, with Anisha Dua, MD, MPH

Leesha Ellis-Cox, MD, MPH: Closing the Bipolar Disorder Diagnosis Gap for Black Adults

Leesha Ellis-Cox, MD, MPH: Closing the Bipolar Disorder Diagnosis Gap for Black Adults

Promising Phase 3 Data for Resmetirom Suggests It May Address ‘Monumental’ Unmet Need in NASH

Promising Phase 3 Data for Resmetirom Suggests It May Address ‘Monumental’ Unmet Need in NASH

The Importance of Adherence in Heart Failure Treatment | STRONG-HF Study

The Importance of Adherence in Heart Failure Treatment | STRONG-HF Study

New Insight: Reengaging the Retina Community in 2024 w/ David Eichenbaum, MD and Roger Goldberg, MD

New Insight: Reengaging the Retina Community in 2024 w/ David Eichenbaum, MD and Roger Goldberg, MD

STRATUM Trial Breakdown: Roflumilast Foam for Seborrheic Dermatitis, with Andrew Blauvelt, MD

STRATUM Trial Breakdown: Roflumilast Foam for Seborrheic Dermatitis, with Andrew Blauvelt, MD

Substance Use Association with Psychiatric Symptoms in Adolescents with Randi M. Schuster, PhD

Substance Use Association with Psychiatric Symptoms in Adolescents with Randi M. Schuster, PhD

Paradigm Shift in Lupus Nephritis Management: KDIGO Guideline Updates with Roger A Levy, MD, PhD

Paradigm Shift in Lupus Nephritis Management: KDIGO Guideline Updates with Roger A Levy, MD, PhD

Discussing Misconceptions, Approaches to Managing Actinic Keratosis with Neal Bhatia, MD

Discussing Misconceptions, Approaches to Managing Actinic Keratosis with Neal Bhatia, MD

Optimal Timing of Continuous Renal Replacement Therapy in Children and Young Adults: Katja Gist, DO

Optimal Timing of Continuous Renal Replacement Therapy in Children and Young Adults: Katja Gist, DO

Interim TEASE-3 Trial Data in Stargardt Disease with Michael B. Gorin, MD, PhD

Interim TEASE-3 Trial Data in Stargardt Disease with Michael B. Gorin, MD, PhD

New Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MD

New Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MD

Crisis Point: Improving Health Equity in Eye Care

Crisis Point: Improving Health Equity in Eye Care

New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD

New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD

Crisis Point: Disparities in Cardiovascular Health

Crisis Point: Disparities in Cardiovascular Health

New Insight: Making Waves in the Biotech Space with Jay Duker, MD

New Insight: Making Waves in the Biotech Space with Jay Duker, MD

New Insight: A Changing Landscape of Retinal Therapeutics with Charles Wykoff, MD, PhD

New Insight: A Changing Landscape of Retinal Therapeutics with Charles Wykoff, MD, PhD

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

The State of Retina Today, and Where We're Heading with Arshad Khanani, MD

The State of Retina Today, and Where We're Heading with Arshad Khanani, MD

Happy Thanksgiving!

Happy Thanksgiving!

Brad Glick, DO, FAAD: Introduction to Derm Discussions

Brad Glick, DO, FAAD: Introduction to Derm Discussions

Alan S. Kliger, MD: Fighting the Flu and COVID-19

Alan S. Kliger, MD: Fighting the Flu and COVID-19

Andrew Moon, MD, MPH: The Future of Liver Disease Treatments

Andrew Moon, MD, MPH: The Future of Liver Disease Treatments

Lakiea Wright, MD: Managing Symptoms of Allergic Asthma

Lakiea Wright, MD: Managing Symptoms of Allergic Asthma

Michael Liebowitz, MD: PH94B Shows Promise Treating Anxiety

Michael Liebowitz, MD: PH94B Shows Promise Treating Anxiety

Paul Christo, MD: Addressing Opioid Addiction during the COVID-19 Pandemic

Paul Christo, MD: Addressing Opioid Addiction during the COVID-19 Pandemic

Alan S. Kliger, MD: Negative COVID-19 Outcomes Common in Kidney Disease Patients

Alan S. Kliger, MD: Negative COVID-19 Outcomes Common in Kidney Disease Patients

Alan S. Kliger, MD: Treating Kidney Diseases During COVID-19

Alan S. Kliger, MD: Treating Kidney Diseases During COVID-19

Anthony Fauci, MD: What Happens After the Pandemic?

Anthony Fauci, MD: What Happens After the Pandemic?

Anthony Fauci, MD: How SARS-CoV-2 Is Most Likely Spread

Anthony Fauci, MD: How SARS-CoV-2 Is Most Likely Spread

Anthony Fauci, MD: COVID-19 Vaccine Understanding is Developing

Anthony Fauci, MD: COVID-19 Vaccine Understanding is Developing

Caleb Alexander, MD: Addressing Shortcomings in the FDA's Opioid Approval Process

Caleb Alexander, MD: Addressing Shortcomings in the FDA's Opioid Approval Process

Paul Christo, MD: The COVID-19 Pandemic and Opioid-Related Deaths

Paul Christo, MD: The COVID-19 Pandemic and Opioid-Related Deaths

Andrew Moon, MD, MPH: Opioid Alternatives for Liver Disease Patients

Andrew Moon, MD, MPH: Opioid Alternatives for Liver Disease Patients

Anthony Fauci, MD: Antibody Research for COVID-19

Anthony Fauci, MD: Antibody Research for COVID-19

Anthony Fauci, MD: How COVID-19 Vaccines Progressed Quickly & Safely

Anthony Fauci, MD: How COVID-19 Vaccines Progressed Quickly & Safely

Michael Liebowitz, MD: Forecasting How COVID-19 Will Effect the Future of Mental Health

Michael Liebowitz, MD: Forecasting How COVID-19 Will Effect the Future of Mental Health

Caleb Alexander, MD: Thoughts on the Opioid Epidemic

Caleb Alexander, MD: Thoughts on the Opioid Epidemic

Lakiea Wright, MD: Allergies, Asthma, and COVID-19

Lakiea Wright, MD: Allergies, Asthma, and COVID-19

Andrew Moon, MD, MPH: Opioid Use High in NAFLD Patients

Andrew Moon, MD, MPH: Opioid Use High in NAFLD Patients

Michael Liebowitz, MD: The Mental Health Impact of COVID-19

Michael Liebowitz, MD: The Mental Health Impact of COVID-19

Lakiea Wright, MD: Dispelling Patient Fears and Concerns Over the Flu Vaccination

Lakiea Wright, MD: Dispelling Patient Fears and Concerns Over the Flu Vaccination

Lakiea Wright, MD: The Importance of Flu Vaccination

Lakiea Wright, MD: The Importance of Flu Vaccination

Lakiea Wright, MD: Differentiating Between Allergies, COVID-19, and Flu

Lakiea Wright, MD: Differentiating Between Allergies, COVID-19, and Flu

Christina Ciaccio, MD, MSc: Treating Patients with Arachis Hypogaea

Christina Ciaccio, MD, MSc: Treating Patients with Arachis Hypogaea

Christina Ciaccio, MD, MSc: Arachis Hypogaea for Peanut Allergy

Christina Ciaccio, MD, MSc: Arachis Hypogaea for Peanut Allergy

Daniel Albert, MD: Telemedicine Challenges for Rheumatologists During COVID-19

Daniel Albert, MD: Telemedicine Challenges for Rheumatologists During COVID-19

Jeffrey Curtis, MD, MS, MPH: The Future of Rheumatological Care

Jeffrey Curtis, MD, MS, MPH: The Future of Rheumatological Care

Lisa Sammaritano, MD: Final Thoughts, ACR Guidelines on Reproductive Health

Lisa Sammaritano, MD: Final Thoughts, ACR Guidelines on Reproductive Health

Daniel Albert, MD: Telemedicine for Rheumatic Care

Daniel Albert, MD: Telemedicine for Rheumatic Care

Alan Kaye, MD, PhD: Treating Pain During COVID-19

Alan Kaye, MD, PhD: Treating Pain During COVID-19

Jeffrey Curtis, MD, MS, MPH: The Responsibility of Cardiovascular Risk Management in Rheumatology

Jeffrey Curtis, MD, MS, MPH: The Responsibility of Cardiovascular Risk Management in Rheumatology

Randall Cron, MD, PhD: Multisystem Inflammatory Syndrome in Children

Randall Cron, MD, PhD: Multisystem Inflammatory Syndrome in Children

Alan Kaye, MD, PhD: The Intersection of Pain and Rheumatology

Alan Kaye, MD, PhD: The Intersection of Pain and Rheumatology

Lisa Sammaritano, MD: Rheumatic Diseases, Pregnancy, and the Importance of Communication

Lisa Sammaritano, MD: Rheumatic Diseases, Pregnancy, and the Importance of Communication

Ashley Crew, MD: The Relationship Between Healthcare Specialists

Ashley Crew, MD: The Relationship Between Healthcare Specialists

Ashley Crew, MD: Barriers to Topical Steroid Use

Ashley Crew, MD: Barriers to Topical Steroid Use

Randall Cron, MD, PhD: Cytokine Storm Syndrome and COVID-19

Randall Cron, MD, PhD: Cytokine Storm Syndrome and COVID-19

Stuart Green, MD: Treating Chronic Cough

Stuart Green, MD: Treating Chronic Cough

Ashley Crew, MD: Clinical Manifestations in Rheum Care Requiring Derm Consult

Ashley Crew, MD: Clinical Manifestations in Rheum Care Requiring Derm Consult

Lars Andersson, PhD: The Future of Personalized Medicine for Asthma

Lars Andersson, PhD: The Future of Personalized Medicine for Asthma

Ashley Crew, MD: The Intersection of Dermatology and Rheumatology

Ashley Crew, MD: The Intersection of Dermatology and Rheumatology

Lisa Sammaritano, MD: Rheumatic Diseases in Pregnant Patients

Lisa Sammaritano, MD: Rheumatic Diseases in Pregnant Patients

Alan Kaye, MD, PhD: Alternates for Rheumatologic Pain

Alan Kaye, MD, PhD: Alternates for Rheumatologic Pain

Michael Wechsler, MD: Asthma Patients During COVID-19

Michael Wechsler, MD: Asthma Patients During COVID-19

Michael Wechsler, MD: Positive Long-Term Data on Dupilumab to Treat Asthma

Michael Wechsler, MD: Positive Long-Term Data on Dupilumab to Treat Asthma

Alan Kaye, MD, PhD: Rheumatology and Pain Management

Alan Kaye, MD, PhD: Rheumatology and Pain Management

Jeffrey Curtis MD, MS, MPH: The Effects of Connective Tissue Diseases on Cardiovascular Risk

Jeffrey Curtis MD, MS, MPH: The Effects of Connective Tissue Diseases on Cardiovascular Risk

Mark Levy, FRCGP: New Technology Improves Asthma Care

Mark Levy, FRCGP: New Technology Improves Asthma Care

Stuart Green, MD: Promising New Drug for Chronic Coughs

Stuart Green, MD: Promising New Drug for Chronic Coughs

Lars Andersson, PhD: Identifying Mediators in Asthma and COPD Patients

Lars Andersson, PhD: Identifying Mediators in Asthma and COPD Patients

Mark Levy, FRCGP: Teaching Asthma Patients Better Inhaler Techniques

Mark Levy, FRCGP: Teaching Asthma Patients Better Inhaler Techniques

Mark Levy, FRCGP: Digital Inhaler Increases Treatment Adherence

Mark Levy, FRCGP: Digital Inhaler Increases Treatment Adherence

Heroes of Healthcare: Lydia Alexander, MD

Heroes of Healthcare: Lydia Alexander, MD

The COVID-19 and Cardiovascular Risk Intersection: 3 Major Considerations

The COVID-19 and Cardiovascular Risk Intersection: 3 Major Considerations

COVID-19 and Cardiovascular Risk: A New Study

COVID-19 and Cardiovascular Risk: A New Study

ESC 2020 Takeaways

ESC 2020 Takeaways

Brian Ference, MD, MPhil, MSc: A New Lifetime Risk Equation for Cardiovascular Disease Risk

Brian Ference, MD, MPhil, MSc: A New Lifetime Risk Equation for Cardiovascular Disease Risk

Keeping Virtual Features in Future Cardiology Meetings

Keeping Virtual Features in Future Cardiology Meetings

How ESC Moved to Virtual Sessions

How ESC Moved to Virtual Sessions

Treating Pediatric FH: PCSK9, Statins, and More

Treating Pediatric FH: PCSK9, Statins, and More

New HAUSER Phase 3 Findings

New HAUSER Phase 3 Findings

Jean-Claude Tardif, MD: APOCIII-Lrx and CV Risk Reduction

Jean-Claude Tardif, MD: APOCIII-Lrx and CV Risk Reduction

Final Thoughts on Ketamine for Major Depressive Disorder

Final Thoughts on Ketamine for Major Depressive Disorder

Adam Simmons, MPH: Promise in Potential New Frontline Schizophrenia Treatment

Adam Simmons, MPH: Promise in Potential New Frontline Schizophrenia Treatment

Adam Simmons, MPH: Reducing Weight Gain for Schizophrenia Treatments

Adam Simmons, MPH: Reducing Weight Gain for Schizophrenia Treatments

Adam Simmons, MPH: ALKS 3831 for Schizophrenia

Adam Simmons, MPH: ALKS 3831 for Schizophrenia

Understanding Ketamine's Antidepressant Effect

Understanding Ketamine's Antidepressant Effect

Jeff Stark, MD: Final Thoughts on ICD-10 Code for nr-ax-SpA

Jeff Stark, MD: Final Thoughts on ICD-10 Code for nr-ax-SpA

Jeff Stark, MD: Diagnosing nr-ax-SpA

Jeff Stark, MD: Diagnosing nr-ax-SpA

Esketamine as Treatment for Major Depressive Disorder

Esketamine as Treatment for Major Depressive Disorder

Jeff Stark, MD: How ICD-10 Codes for nr-ax-SpA Affect Other Rheumatic Diseases

Jeff Stark, MD: How ICD-10 Codes for nr-ax-SpA Affect Other Rheumatic Diseases

J. John Mann, MD: The Evolution of Antidepressant Research

J. John Mann, MD: The Evolution of Antidepressant Research

Jeff Stark, MD: How ICD-10 Codes Affect nr-ax-SpA Treatment

Jeff Stark, MD: How ICD-10 Codes Affect nr-ax-SpA Treatment

Stephen Hanauer, MD: Gastrointestinal Symptoms Mild in COVID-19

Stephen Hanauer, MD: Gastrointestinal Symptoms Mild in COVID-19

Erica Brenner, MD: Returning to Normal in Gastroenterology

Erica Brenner, MD: Returning to Normal in Gastroenterology

Jeff Stark, MD: The Process of nr-ax-SpA Indexed to ICD-10

Jeff Stark, MD: The Process of nr-ax-SpA Indexed to ICD-10

Erica Brenner, MD: The Success of the SECURE-IBD Database

Erica Brenner, MD: The Success of the SECURE-IBD Database

Jeff Stark, MD: The Importance of ICD-10 Codes for nr-ax-SpA

Jeff Stark, MD: The Importance of ICD-10 Codes for nr-ax-SpA

Erica Brenner, MD: What We've Learned about IBD Patients with COVID-19

Erica Brenner, MD: What We've Learned about IBD Patients with COVID-19

Naahaad Mukadam, PhD: Addressing the Dementia Public Health Crisis

Naahaad Mukadam, PhD: Addressing the Dementia Public Health Crisis

Naahaad Mukadam, PhD: The Future of Dementia Care

Naahaad Mukadam, PhD: The Future of Dementia Care

Eugenia South, MD, MSHP: COVID-19 and Nature

Eugenia South, MD, MSHP: COVID-19 and Nature

Eugenia South, MD, MSHP: Nature and the Role of the Provider

Eugenia South, MD, MSHP: Nature and the Role of the Provider

Kim Kjøller, MD: BLA for Tralokinumab and the Next Steps

Kim Kjøller, MD: BLA for Tralokinumab and the Next Steps

Kim Kjøller, MD: Comparing Tralokinumab to Other Agents for Atopic Dermatitis

Kim Kjøller, MD: Comparing Tralokinumab to Other Agents for Atopic Dermatitis

What's Next in Voxelotor Research

What's Next in Voxelotor Research

How Voxelotor Benefits the Blood Shortage

How Voxelotor Benefits the Blood Shortage

How New Therapies Could Revolutionize Sickle Cell Disease

How New Therapies Could Revolutionize Sickle Cell Disease

How VTE Screening Can Be Improved

How VTE Screening Can Be Improved

Voxelotor in Sickle Cell Disease

Voxelotor in Sickle Cell Disease

Improving Ophthalmology Screening and Telemedicine

Improving Ophthalmology Screening and Telemedicine

What's the Cross-Specialty Collaboration with Ophthalmology?

What's the Cross-Specialty Collaboration with Ophthalmology?

How Diabetics Progress to Retina Complications

How Diabetics Progress to Retina Complications

How Ophthalmology Has Evolved During COVID-19

How Ophthalmology Has Evolved During COVID-19

The Burdens of Nonproliferative Diabetic Retinopathy

The Burdens of Nonproliferative Diabetic Retinopathy

Aflibercept Injection for Nonproliferative Diabetic Retinopathy

Aflibercept Injection for Nonproliferative Diabetic Retinopathy

Kim Kjøller, MD: Results of Tralokinumab Trial

Kim Kjøller, MD: Results of Tralokinumab Trial

Kim Kjøller, MD: Tralokinumab for Atopic Dermatitis

Kim Kjøller, MD: Tralokinumab for Atopic Dermatitis

Eugenia South, MD, MSHP: Addressing Nature and Other Social Determinants

Eugenia South, MD, MSHP: Addressing Nature and Other Social Determinants